目次

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.1.2 List of key secondary sources
2.1.1.3 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key objectives of primary research
2.1.2.2 List of primary sources
2.1.2.3 Key data from primary sources
2.1.2.4 Breakdown of primary interviews
2.1.2.5 Insights from industry experts
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Revenue estimation of key players
2.2.1.2 Study of annual reports and investor presentations
2.2.1.3 Primary interviews
2.2.1.4 Growth forecast
2.2.1.5 CAGR projections
2.2.2 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 STUDY ASSUMPTIONS
2.4.1 RESEARCH-RELATED ASSUMPTIONS
2.4.2 PARAMETRIC ASSUMPTIONS
2.4.3 ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN INFECTION CONTROL MARKET
4.2 ASIA PACIFIC: INFECTION CONTROL MARKET, BY END USER AND COUNTRY
4.3 INFECTION CONTROL MARKET, BY COUNTRY
4.4 INFECTION CONTROL MARKET, BY REGION

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of HAIs
5.2.1.2 Increasing number of surgical procedures
5.2.1.3 Advancements in reprocessing technologies
5.2.1.4 Increasing emphasis on sterilization & disinfection of food
5.2.1.5 Advancements in sterilization equipment technology
5.2.1.6 Growing trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals
5.2.2 RESTRAINTS
5.2.2.1 Growing concerns about safety of reprocessed instruments
5.2.2.2 Consequences associated with chemical disinfectant use
5.2.2.3 High cost of endoscopy reprocessing and limited reimbursements
5.2.3 OPPORTUNITIES
5.2.3.1 Growing presence of medical device and pharmaceutical companies in developing nations
5.2.3.2 Reintegration of ethylene oxide sterilization
5.2.3.3 Growing utilization of E-beam sterilization
5.2.4 CHALLENGES
5.2.4.1 Sterilization of advanced medical devices
5.2.4.2 Alternative methods for surface disinfection
5.2.4.3 Increasing adoption of single-use medical devices
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY TYPE, 2023-2025
5.4.2 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY KEY PLAYER, 2023-2025
5.4.3 AVERAGE SELLING PRICE TREND OF INFECTION CONTROL PRODUCTS, BY REGION, 2023-2025
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT & FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Heat sterilization
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 Ultra-high-pressure sterilization
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Nitrogen dioxide (NO2)
5.10 PATENT ANALYSIS
5.10.1 LIST OF KEY PATENTS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 841920
5.11.2 EXPORT DATA FOR HS CODE 841920
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 CASE STUDY ANALYSIS
5.13.1 CASE STUDY 1: DILUTION DYSFUNCTION - EVALUATION OF AUTOMATED DISINFECTANT DISPENSER SYSTEMS IN 10 HOSPITALS
5.13.2 CASE STUDY 2: IMPLEMENTATION OF A NOVEL COLOR ADDITIVE FOR BLEACH DISINFECTANT WIPES ENHANCES CLEANING PERFORMANCE IN AN ACADEMIC MEDICAL CENTER
5.13.3 CASE STUDY 3: THE IMPACT OF ENHANCED CLEANING ON BACTERIAL CONTAMINATION OF HOSPITAL ENVIRONMENTAL SURFACES - A CLINICAL TRIAL IN CRITICAL CARE UNITS, EGYPT
5.14 REGULATORY ANALYSIS
5.14.1 REGULATORY LANDSCAPE
5.14.1.1 North America
5.14.1.1.1 US
5.14.1.1.2 Canada
5.14.1.2 Europe
5.14.1.3 Asia Pacific
5.14.1.3.1 Japan
5.14.1.3.2 China
5.14.1.3.3 Australia
5.14.1.4 Latin America
5.14.1.4.1 Brazil
5.14.1.4.2 Mexico
5.14.1.5 Middle East
5.14.1.6 Africa
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15 PORTER’S FIVE FORCES ANALYSIS
5.15.1 BARGAINING POWER OF SUPPLIERS
5.15.2 BARGAINING POWER OF BUYERS
5.15.3 THREAT OF NEW ENTRANTS
5.15.4 THREAT OF SUBSTITUTES
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 KEY BUYING CRITERIA
5.17 IMPACT OF AI/GEN AI ON INFECTION CONTROL MARKET
5.17.1 INTRODUCTION
5.17.2 POTENTIAL OF AI
5.17.3 IMPACT OF AI
5.17.4 KEY COMPANIES IMPLEMENTING AI
5.17.5 FUTURE OF AI
5.18 IMPACT OF 2025 US TARIFFS ON INFECTION CONTROL MARKET
5.18.1 INTRODUCTION
5.18.2 KEY TARIFF RATES
5.18.3 PRICE IMPACT ANALYSIS
5.18.4 IMPACT ON COUNTRY/REGION
5.18.4.1 North America
5.18.4.2 Europe
5.18.4.3 Asia Pacific
5.18.5 IMPACT ON END-USE INDUSTRIES
5.18.5.1 Hospitals & clinics
5.18.5.2 Medical device companies
5.18.5.3 Pharmaceutical & life science industry
5.18.5.4 Food industry

6 INFECTION CONTROL MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 STERILIZATION PRODUCTS & SERVICES
6.2.1 STERILIZATION EQUIPMENT
6.2.1.1 Heat sterilization equipment
6.2.1.1.1 Moist heat sterilizers
6.2.1.1.1.1 Versatility across material testing to fuel market growth
6.2.1.1.2 Dry heat sterilizers
6.2.1.1.2.1 Increasing demand for heat-sensitive instruments to boost demand
6.2.1.2 Low-temperature sterilization equipment
6.2.1.2.1 Hydrogen peroxide sterilizers
6.2.1.2.1.1 Effective application across broad industries to fuel market
6.2.1.2.2 Ethylene oxide (EtO) sterilizers
6.2.1.2.2.1 High penetration capabilities to fuel uptake
6.2.1.2.3 Formaldehyde sterilizers
6.2.1.2.3.1 Potent antimicrobial properties to aid adoption
6.2.1.2.4 Other low-temperature sterilization equipment
6.2.1.3 Radiation sterilizers
6.2.1.3.1 Utilization across pharmaceutical & biopharmaceutical sectors for vaccines & biologics to drive market
6.2.2 CONTRACT STERILIZATION SERVICES
6.2.2.1 EtO sterilization services
6.2.2.1.1 Expanding applications across medical device sterilization and life science industry to fuel market
6.2.2.2 Gamma sterilization services
6.2.2.2.1 Minimal chemical residue and ability to penetrate dense materials to fuel uptake
6.2.2.3 E-beam sterilization services
6.2.2.3.1 Rapid processing and precise control to boost market
6.2.2.4 Steam sterilization services
6.2.2.4.1 Standard method with optimal efficiency to drive market
6.2.2.5 Other contract sterilization services
6.3 STERILIZATION ACCESSORIES
6.3.1 STERILIZATION INDICATORS
6.3.1.1 Chemical indicators
6.3.1.1.1 Low cost of chemical indicators to aid adoption
6.3.1.2 Biological indicators
6.3.1.2.1 Efficacy of biological indicators to drive demand
6.3.1.3 Sterilization pouches
6.3.1.3.1 Sterility maintenance with time duration to aid adoption
6.3.1.4 Sterilization lubricants
6.3.1.4.1 Prevention of equipment damage to support market growth
6.3.2 OTHER STERILIZATION ACCESSORIES
6.4 STERILIZATION CONSUMABLES
6.4.1 INCREASING DEMAND FOR STERILANTS IN FOOD & MEDICAL DEVICE INDUSTRIES TO SUPPORT MARKET GROWTH
6.5 CLEANING & DISINFECTION PRODUCTS
6.5.1 DISINFECTANTS
6.5.1.1 Disinfectants, by product type
6.5.1.1.1 Hand disinfectants
6.5.1.1.1.1 Rising awareness about health & hygiene to boost market
6.5.1.1.2 Surface disinfectants
6.5.1.1.2.1 Increasing prevalence of HAIs to fuel market
6.5.1.1.3 Skin disinfectants
6.5.1.1.3.1 Increasing incidence of infectious diseases to fuel market
6.5.1.1.4 Instrument disinfectants
6.5.1.1.4.1 Growing number of surgical procedures to boost demand
?
6.5.1.2 Disinfectants, by formulation
6.5.1.2.1 Disinfectant wipes
6.5.1.2.1.1 Easy accessibility to support market growth
6.5.1.2.2 Liquid disinfectants
6.5.1.2.2.1 Effective utilization and high affordability to propel market
6.5.1.2.3 Disinfectant sprays
6.5.1.2.3.1 Increasing usage of antimicrobial control measures to fuel demand
6.5.1.3 Disinfectants, by EPA classification
6.5.1.3.1 Low-level disinfectants
6.5.1.3.1.1 Effective elimination of vegetative bacteria and most viruses to boost demand
6.5.1.3.2 Intermediate-level disinfectants
6.5.1.3.2.1 Applications across dentistry and environmental monitoring to boost demand
6.5.1.3.3 High-level disinfectants
6.5.1.3.3.1 Sterilization of medical devices and semi-critical instruments across clinical settings to propel uptake
6.5.2 CLEANING & DISINFECTION EQUIPMENT
6.5.2.1 Washer disinfectors
6.5.2.1.1 Utilization of high-pressure water jets and detergents for disinfection to fuel market
6.5.2.2 Flusher disinfectors
6.5.2.2.1 Innovative product launches to boost demand
6.5.2.3 UV-ray disinfectors
6.5.2.3.1 Elimination of plethora of viruses, bacteria, and fungi to propel market
6.5.2.4 Ultrasonic cleaners
6.5.2.4.1 Utilization of high-frequency sound waves for microscopic dirt clearance to aid adoption
6.5.2.5 Other cleaning & disinfection equipment
6.5.3 LUBRICANTS & CLEANING SOLUTIONS
6.5.3.1 Utilization for disinfection of reprocessing instruments to drive market
6.5.4 DISINFECTION & CLEANING ACCESSORIES
6.5.4.1 Stringent regulatory standards to support market growth
6.6 PROTECTIVE BARRIERS
6.6.1 MEDICAL NONWOVENS
6.6.1.1 Face masks
6.6.1.1.1 Increasing prevalence of respiratory diseases to drive market
6.6.1.2 Surgical gowns
6.6.1.2.1 Growing awareness about infection control to fuel market
?
6.6.1.3 Surgical drapes
6.6.1.3.1 Prevention of microorganism transfer from non-sterile surfaces to fuel uptake
6.6.2 COVERS & CLOSURES
6.6.2.1 Growing focus on food safety to fuel demand
6.6.3 GOGGLES
6.6.3.1 Increasing use of protective gear in research laboratories to support market growth
6.6.4 GLOVES
6.6.4.1 Growing concerns related to personnel safety to fuel uptake
6.7 ENDOSCOPE REPROCESSING PRODUCTS
6.7.1 ENDOSCOPE REPROCESSING CONSUMABLES
6.7.1.1 Rising number of endoscope procedures to fuel uptake
6.7.2 ENDOSCOPE REPROCESSING EQUIPMENT
6.7.2.1 Automated endoscope reprocessors
6.7.2.1.1 Growing impact of automated endoscope reprocessors on healthcare expansion to accelerate growth
6.7.2.2 Endoscope drying, storage, and transport systems
6.7.2.2.1 Need for patient safety and efficient reprocessing workflow to accelerate growth
6.7.3 ENDOSCOPE TRACKING SOLUTIONS
6.7.3.1 Improved traceability and supervision to foster growth
6.8 OTHER INFECTION CONTROL PRODUCTS

7 INFECTION CONTROL MARKET, BY END USER
7.1 INTRODUCTION
7.2 HOSPITALS & CLINICS
7.2.1 STRINGENT CLEANLINESS PROTOCOLS FOR RESTRICTION OF HAIS TO PROPEL MARKET
7.3 MEDICAL DEVICE COMPANIES
7.3.1 RISING TECHNOLOGICAL INNOVATIONS IN INFECTION CONTROL PRODUCTS TO DRIVE MARKET
7.4 PHARMACEUTICAL COMPANIES
7.4.1 GROWING NEED FOR SAFETY ASSURANCE AND REGULATORY APPROVALS TO BOOST MARKET
7.5 LIFE SCIENCE INDUSTRY
7.5.1 INCREASING FOCUS ON CLINICAL RESEARCH INITIATIVES TO FUEL MARKET
7.6 FOOD INDUSTRY
7.6.1 RISING INCIDENCE OF FOODBORNE DISEASES TO SUPPORT MARKET GROWTH
7.7 OTHER END USERS
?

8 INFECTION CONTROL MARKET, BY REGION
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
8.2.2 US
8.2.2.1 Rising prevalence of healthcare-associated infections (HAIs) to drive market
8.2.3 CANADA
8.2.3.1 Rising geriatric population to support market growth
8.3 EUROPE
8.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
8.3.2 GERMANY
8.3.2.1 Growing adoption of hospital disinfection & surveillance systems to drive market
8.3.3 UK
8.3.3.1 High prevalence of HAIs to drive market
8.3.4 FRANCE
8.3.4.1 Stringent regulatory guidelines for infection control product commercialization to fuel uptake
8.3.5 ITALY
8.3.5.1 Increasing establishment of long-term care facilities to boost demand
8.3.6 SPAIN
8.3.6.1 Increasing prevalence of infectious diseases to fuel market
8.3.7 SWITZERLAND
8.3.7.1 Heightened burden of CAUTI to drive market
8.3.8 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
8.4.2 JAPAN
8.4.2.1 Increasing geriatric population and healthcare expenditure to drive market
8.4.3 CHINA
8.4.3.1 Rising healthcare spending and increasing prevalence of chronic diseases to drive market
8.4.4 INDIA
8.4.4.1 Extensive patient population to boost growth
8.4.5 AUSTRALIA
8.4.5.1 Increasing demand for healthcare services to support market growth
8.4.6 SOUTH KOREA
8.4.6.1 Increasing government efforts to broaden healthcare coverage to drive market
8.4.7 REST OF ASIA PACIFIC
?
8.5 LATIN AMERICA
8.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
8.5.2 BRAZIL
8.5.2.1 Established pharmaceutical and biotechnology industries to drive market
8.5.3 MEXICO
8.5.3.1 Increasing prevalence of chronic disorders to aid market growth
8.5.4 REST OF LATIN AMERICA
8.6 MIDDLE EAST & AFRICA
8.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
8.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
8.7 GCC COUNTRIES
8.7.1 HIGHER DISPOSABLE INCOMES TO DRIVE DEMAND FOR HEALTHCARE SERVICES
8.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

9 COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2022-2025
9.2.1 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN INFECTION CONTROL MARKET
9.3 REVENUE ANALYSIS, 2022-2024
9.4 MARKET SHARE ANALYSIS, 2024
9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
9.5.1 STARS
9.5.2 EMERGING LEADERS
9.5.3 PERVASIVE PLAYERS
9.5.4 PARTICIPANTS
9.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
9.5.5.1 Company footprint
9.5.5.2 Region footprint
9.5.5.3 Product & service footprint
9.5.5.4 End-user footprint
9.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
9.6.1 PROGRESSIVE COMPANIES
9.6.2 RESPONSIVE COMPANIES
9.6.3 DYNAMIC COMPANIES
9.6.4 STARTING BLOCKS
9.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024
9.6.5.1 Detailed list of key startups/SMEs
9.6.5.2 Competitive benchmarking of start-ups/SMEs
9.7 COMPANY VALUATION & FINANCIAL METRICS
9.8 BRAND/PRODUCT COMPARISON
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT LAUNCHES
9.9.2 DEALS
9.9.3 EXPANSIONS
9.9.4 OTHER DEVELOPMENTS

10 COMPANY PROFILES
10.1 KEY PLAYERS
10.1.1 STERIS
10.1.1.1 Business overview
10.1.1.2 Products/Services offered
10.1.1.3 Recent developments
10.1.1.3.1 Product launches & approvals
10.1.1.3.2 Deals
10.1.1.3.3 Expansions
10.1.1.4 MnM view
10.1.1.4.1 Right to win
10.1.1.4.2 Strategic choices
10.1.1.4.3 Weaknesses & competitive threats
10.1.2 RECKITT BENCKISER GROUP PLC
10.1.2.1 Business overview
10.1.2.2 Products/Services offered
10.1.2.3 Recent developments
10.1.2.3.1 Product launches
10.1.2.3.2 Deals
10.1.2.4 MnM view
10.1.2.4.1 Right to win
10.1.2.4.2 Strategic choices
10.1.2.4.3 Weaknesses & competitive threats
10.1.3 FORTIVE
10.1.3.1 Business overview
10.1.3.2 Products/Services offered
10.1.3.3 MnM view
10.1.3.3.1 Right to win
10.1.3.3.2 Strategic choices
10.1.3.3.3 Weaknesses & competitive threats
10.1.4 SOTERA HEALTH
10.1.4.1 Business overview
10.1.4.2 Products/Services offered
10.1.4.3 Recent developments
10.1.4.3.1 Expansions
?
10.1.4.4 MnM view
10.1.4.4.1 Right to win
10.1.4.4.2 Strategic choices
10.1.4.4.3 Weaknesses & competitive threats
10.1.5 SOLVENTUM
10.1.5.1 Business overview
10.1.5.2 Products/Services offered
10.1.5.3 Recent developments
10.1.5.3.1 Product launches
10.1.5.3.2 Other developments
10.1.5.4 MnM view
10.1.5.4.1 Right to win
10.1.5.4.2 Strategic choices
10.1.5.4.3 Weaknesses & competitive threats
10.1.6 GETINGE AB
10.1.6.1 Business overview
10.1.6.2 Products/Services offered
10.1.6.3 Recent developments
10.1.6.3.1 Product launches
10.1.6.3.2 Deals
10.1.7 ECOLAB, INC.
10.1.7.1 Business overview
10.1.7.2 Products/Services offered
10.1.7.3 Recent developments
10.1.7.3.1 Product launches
10.1.7.3.2 Deals
10.1.8 OLYMPUS CORPORATION
10.1.8.1 Business overview
10.1.8.2 Products/Services offered
10.1.8.3 Recent developments
10.1.8.3.1 Product launches
10.1.8.3.2 Deals
10.1.8.3.3 Expansions
10.1.9 ENVISTA
10.1.9.1 Business overview
10.1.9.2 Products/Services offered
10.1.10 PAUL HARTMANN AG
10.1.10.1 Business overview
10.1.10.2 Products/Services offered
10.1.11 B. BRAUN SE
10.1.11.1 Business overview
10.1.11.2 Products/Services offered
10.1.11.3 Recent developments
10.1.11.3.1 Other developments
10.1.12 KIMBERLY-CLARK CORPORATION
10.1.12.1 Business overview
10.1.12.2 Products/Services offered
10.1.13 CARDINAL HEALTH
10.1.13.1 Business overview
10.1.13.2 Products/Services offered
10.1.13.3 Recent developments
10.1.13.3.1 Expansions
10.1.14 PROCTER & GAMBLE
10.1.14.1 Business overview
10.1.14.2 Products/Services offered
10.1.15 THE CLOROX COMPANY
10.1.15.1 Business overview
10.1.15.2 Products/Services offered
10.1.15.3 Recent developments
10.1.15.3.1 Deals
10.1.16 STRYKER CORPORATION
10.1.16.1 Business overview
10.1.16.2 Products/Services offered
10.1.17 HOYA CORPORATION
10.1.17.1 Business overview
10.1.17.2 Products/Services offered
10.1.17.3 Recent developments
10.1.17.3.1 Deals
10.1.18 CONMED CORPORATION
10.1.18.1 Business overview
10.1.18.2 Products/Services offered
10.1.19 FUJIFILM HOLDINGS CORPORATION
10.1.19.1 Business overview
10.1.19.2 Products/Services offered
10.2 OTHER PLAYERS
10.2.1 MIELE GROUP (JOINT VENTURE WITH METALL ZUG)
10.2.2 MMM GROUP
10.2.3 ANTONIO MATACHANA, S.A.
10.2.4 PAL INTERNATIONAL
10.2.5 SYSTEC GMBH & CO.KG
10.2.6 CONTEC, INC.
10.2.7 MEDALKAN
10.2.8 DR. SCHUMACHER GMBH
10.2.9 ULTRAWAVE
10.2.10 SCHÜLKE & MAYR GMBH
10.2.11 STERITEK INC.

11 APPENDIX
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS